Assuming that rapid-acting insulin analogs last for 5 hours is a safe general rule. Examples include Aspart (Novolog) and Lispro (Humalog). Regular human insulin: The onset of regular human ...

Objective: To compare traditional sliding scale (SS) with a tight glycemic control ... was compared with those treated with TC (n = 210). Patients on SS insulin received a traditional SS regimen ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus. HealthDay News — ...

A smart scale can go beyond just tracking your weight. If you're investing in your health, you might start watching your weight as a part of your journey. However, there are a lot of different ...

Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to Novo Nordisk’s Novolog) that helps control blood sugar spikes when taken five to 10 minutes before a meal.

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...

The FDA has approved Sanofi’s Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) to improve glycemic control in adults and pediatric patients with diabetes. Merilog is a ...

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...